CDE Catalog

View and download available CureSCi CDEs using filters below. For best results, clear form between searches.

Displaying 5126 - 5150 of 5231
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far right side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification Version Number Version Date CRF Name ©, ® or TM Disease Name Sub Disease Name
C60607 Priapism erection duration text

Text field for capturing the value and units of the duration of erection reported by the subject/participant.

Core 1.00 2021-04-29 13:27:59.0 Priapism Core Sickle Cell Disease Sickle Cell Disease
C60608 Priapism erection percent value

Value of the percentage of the subject/participant's penis that is erect.

Core 1.00 2021-04-29 13:30:01.0 Priapism Core Sickle Cell Disease Sickle Cell Disease
C60609 Priapism intervention type

Type(s) of interventions provided to the subject/participant for his priapism.

Core 1.00 2021-04-29 13:31:43.0 Priapism Core Sickle Cell Disease Sickle Cell Disease
C60610 Priapism duration until resolution discharge home text

Text for reporting the value and units of the duration of the subject/participant's episode of priapism until resolution or discharge home.

Core 1.00 2021-04-29 13:37:49.0 Priapism Core Sickle Cell Disease Sickle Cell Disease
C60611 Priapism prevention medication prescribe indicator

Indicator of whether the subject/participant was prescribed any medications for prevention of priapism.

Core 1.00 2021-04-29 13:39:51.0 Priapism Core Sickle Cell Disease Sickle Cell Disease
C60612 Priapism prevention medication prescribe type

Type(s) of medications prescribed for the prevention of priapism.

Core 1.00 2021-04-29 13:41:40.0 Priapism Core Sickle Cell Disease Sickle Cell Disease
C60613 Pain 15 day per month minimum 6 month indicator

Indicator of whether the subject/participant has experienced pain on at least 15 days per month for at least 6 months.

Core 1.00 2021-04-29 13:44:59.0 Chronic Pain Sickle Cell Disease Sickle Cell Disease
C60614 Pain sign present type

Type(s) of signs of pain present with the subject/participant.

Core 1.00 2021-04-29 13:48:14.0 Chronic Pain Sickle Cell Disease Sickle Cell Disease
C60615 Smoking start year integer

Integer identifying the year in which the subject/participant began smoking.

Core 1.00 2021-04-29 13:59:09.0 Behavioral History Short Form Sickle Cell Disease Sickle Cell Disease
C60617 Smoking stop year integer

Integer identifying the year in which the subject/participant stopped smoking.

Core 1.00 2021-04-29 13:59:09.0 Behavioral History Short Form Sickle Cell Disease Sickle Cell Disease
C60616 Cigarette pack per day maximum count

Count of packs per day the subject/participant smoked when he or she was smoking the most.

Core 1.00 2021-04-29 14:03:05.0 Behavioral History Short Form Sickle Cell Disease Sickle Cell Disease
C60618 Alcohol history status

Status of the subject/participant's history of alcohol consumption.

Supplemental - Highly Recommended 1.00 2021-04-29 14:08:05.0 Behavioral History Short Form Sickle Cell Disease Sickle Cell Disease
C60619 Alcohol drink per week maximum count

Count of alcoholic drinks per week consumed by the subject/participant in the period of his or her maximum alcohol consumption.

Supplemental - Highly Recommended 1.00 2021-04-29 14:10:51.0 Behavioral History Short Form Sickle Cell Disease Sickle Cell Disease
C60620 Drug use history status

Status of the subject/participant's history of drug use.

Supplemental - Highly Recommended 1.00 2021-04-29 14:13:25.0 Behavioral History Short Form Sickle Cell Disease Sickle Cell Disease
C60621 Drug illicit use type

Type(s) of illicit drugs used by the subject/participant

Supplemental - Highly Recommended 1.00 2021-04-29 14:17:31.0 Behavioral History Short Form Sickle Cell Disease Sickle Cell Disease
C60622 Immunoglobulin A measurement

Measurement, in milligrams per deciliter (mg/dL), of serum Immunoglobulin A (IgA)

Core 1.00 2021-04-29 14:32:19.0 Immune Reconstitution Core Sickle Cell Disease Sickle Cell Disease
C60623 Immunoglobulin G measurement

Measurement, in milligrams per deciliter (mg/dL), of serum Immunoglobulin G (IgG)

Core 1.00 2021-04-29 14:32:19.0 Immune Reconstitution Core Sickle Cell Disease Sickle Cell Disease
C60624 Immunoglobulin M measurement

Measurement, in milligrams per deciliter (mg/dL), of serum Immunoglobulin M (IgM)

Core 1.00 2021-04-29 14:32:19.0 Immune Reconstitution Core Sickle Cell Disease Sickle Cell Disease
C60625 Bone marrow aspirate biopsy prior initiation curative therapy conditioning regimen indicator

Indicator of whether bone marrow aspirate/biopsy was performed prior to the initiation of a conditioning regimen for curative therapy.

Core 1.00 2021-04-29 14:44:11.0 Baseline Abnormal Hematopoiesis Sickle Cell Disease Sickle Cell Disease
C60626 Imaging MRI liver indicator

Indicator of whether magnetic resonance imaging (MRI) of the liver was performed.

Core 1.00 2021-04-29 14:47:32.0 Iron Overload Sickle Cell Disease Sickle Cell Disease
C60627 Imaging MRI liver iron content status

Status of the liver iron content (LIC) obtained from magnetic resonance imaging (MRI)

Core 1.00 2021-04-29 14:49:32.0 Iron Overload Sickle Cell Disease Sickle Cell Disease
C60628 Imaging MRI liver iron content detemination method type

Type of method used for determination of liver iron content (LIC) in magnetic resonance imaging (MRI).

Core 1.00 2021-04-29 14:54:01.0 Iron Overload Sickle Cell Disease Sickle Cell Disease
C60629 Liver biopsy iron result text

Text field for reporting the result of the laboratory iron test for liver biopsy.

Core 1.00 2021-04-29 14:59:31.0 Iron Overload Sickle Cell Disease Sickle Cell Disease
C60630 Liver biopsy serum transferrin saturation percent value

Value of the percentage of serum transferrin saturation detemined by laboratory anaylsis of liver biopsy sample.

Core 1.00 2021-04-29 15:01:38.0 Iron Overload Sickle Cell Disease Sickle Cell Disease
C60631 Elapsed time from infusion at visit category

Category of elapsed time since infusion as of the visit being documented.

Core 1.00 2021-04-29 16:11:55.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
Displaying 5126 - 5150 of 5231